Loss of Interleukin Receptor-Associated Kinase 4 Signaling Suppresses Amyloid Pathology and Alters Microglial Phenotype in a Mouse Model of Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is typified by the deposition of amyloid in the brain, which elicits a robust microglial-mediated inflammatory response that is associated with disease exacerbation and accelerated progression. Microglia are the principal immune effector cells in the brain and interact with fibrillar forms of Aβ (fAβ) through a receptor complex that includes Toll-like receptors (TLR) 2/4/6 and their coreceptors. Interleukin receptor-associated kinases (IRAKs) are essential intracellular signaling molecules for transduction of TLR signals. Studies of mouse models of AD in which the individual TLRs are knocked out have produced conflicting results on roles of TLR signaling in amyloid homeostasis. Therefore, we disrupted a common downstream TLR signaling element, IRAK4. We report that microglial IRAK4 is necessary in vitro for fAβ to activate the canonical pro-inflammatory signaling pathways leading to activation of p38, JNK, and ERK MAP kinases and to generate reactive oxygen species.In vivo the loss of IRAK4 function results in decreased Aβ levels in a murine model of AD. This was associated with diminished microgliosis and astrogliosis in aged mice. Analysis of microglia isolated from the adult mouse brain revealed an altered pattern of gene expression associated with changes in microglial phenotype that were associated with expression of IRF transcription factors that govern microglial phenotype. Further, loss of IRAK4 function also promoted amyloid clearance mechanisms, including elevated expression of insulin-degrading enzyme. Finally, blocking IRAK function restored olfactory behavior. These data demonstrate that IRAK4 activation acts normally to regulate microglial activation status and influence amyloid homeostasis in the brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Querfurth, H. W., & LaFerla, F. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmra0909142 · Cited by 4,569
Alternative activation of macrophages: mechanism and functions
Gordon, S., & Martinez, F. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.05.007 · Cited by 4,197 · cited 2×
“The recent appreciation of the phenotypic heterogeneity of microglia has resulted in their classification as surveillant, M1 or M2, analogous to phenotypic states observed in peripheral mac- rophages (Mosser and Edwards, 2008; Gordon and Martinez, 2010).”
BackgroundToll-like receptors and their crosstalk with other innate receptors in infection and immunity
Kawai, T., & Akira, S. (2011) · Immunity · doi:10.1016/j.immuni.2011.05.006 · Cited by 3,658 · cited 3×
“These studies are congruent with those of Scholtzova et al. (2009) who reported that TLR9 activation was associated with reduced amyloid deposition, a treatment that is known to drive a strong interferon response (Kawai and Akira, 2011).”
BackgroundResultDecreased Clearance of CNS β-Amyloid in Alzheimer’s Disease
Mawuenyega, K. G., Sigurdson, W., Ovod, V., Munsell, L., Kasten, T., Morris, J. C., Yarasheski, K. E., & Bateman, R. J. (2010) · Science · doi:10.1126/science.1197623 · Cited by 2,078 · cited 1×
“How amyloid deposition, and the immune response to it, influences the clearance of amyloid is of importance in light of recent evidence that sporadic forms of AD arise from impaired clearance of A from the brain (Mawuenyega et al., 2010).”
BackgroundAlzheimer’s Disease: The Challenge of the Second Century
Holtzman, D. M., Morris, J. C., & Goate, A. M. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002369 · Cited by 1,424
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329 · cited 6×
“Isolation of adult microglia was performed as previously described (Hickman et al., 2008).”
BackgroundMethodResultInfluentialBeta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Satoh, T., Takeuchi, O., Vandenbon, A., Yasuda, K., Tanaka, Y., Kumagai, Y., Miyake, T., Matsushita, K., Okazaki, T., Saitoh, T., et al. (2010) · Nature Immunology · doi:10.1038/ni.1920 · Cited by 1,156
Helical Assembly in the MyD88-IRAK4-IRAK2 Complex in TLR/IL-1R Signalling
Lin, S.-C., Lo, Y.-C., & Wu, H. (2010) · Nature · doi:10.1038/nature09121 · Cited by 1,111 · cited 1×
“These studies are all confounded by the integral structural role that MyD88 plays in the assembly of the intracellular signaling platform for TLR signaling (Motshwene et al., 2009; Lin et al., 2010), which would be disrupted by knocking out MyD88.”
BackgroundAssembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs.
Burdick, D., Soreghan, B., Kwon, M., Kosmoski, J., Knauer, M., Henschen, A., Yates, J., Cotman, C., & Glabe, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48529-8 · Cited by 1,014
CD14 Controls the LPS-Induced Endocytosis of Toll-like Receptor 4
Zanoni, I., Ostuni, R., Marek, L. R., Barresi, S., Barbalat, R., Barton, G. M., Granucci, F., & Kagan, J. C. (2011) · Cell · doi:10.1016/j.cell.2011.09.051 · Cited by 997
Rapid appearance and local toxicity of amyloid-β plaques in a mouse model of Alzheimer’s disease
Meyer-Luehmann, M., Spires-Jones, T. L., Prada, C., Garcia-Alloza, M., de Calignon, A., Rozkalne, A., Koenigsknecht-Talboo, J., Holtzman, D. M., Bacskai, B. J., & Hyman, B. T. (2008) · Nature · doi:10.1038/nature06616 · Cited by 987 · cited 4×
“Furthermore, plaque formation is associated with dysmorphic neurites (Hickman et al., 2008; Meyer-Luehmann et al., 2008).”
BackgroundInfluentialAβ42‐driven cerebral amyloidosis in transgenic mice reveals early and robust pathology
Radde, R., Bolmont, T., Kaeser, S. A., Coomaraswamy, J., Lindau, D., Stoltze, L., Calhoun, M. E., Jäggi, F., Wolburg, H., Gengler, S., et al. (2006) · The EMBO Reports · doi:10.1038/sj.embor.7400784 · Cited by 986 · cited 5×
“APPPS1–21, referred to as APPPS1, mice carrying the KM670/ 671NL mutation in human amyloid precursor protein and L166P mutation in presenilin 1 on a C57BL/6J background have previously been described (Radde et al., 2006) and were obtained from Dr. Mathias Jucker (University of Tübingen, Germany).”
BackgroundMethodInfluentialApoE Promotes the Proteolytic Degradation of Aβ
Jiang, Q., Lee, C. Y. D., Mandrekar, S., Wilkinson, B., Cramer, P., Zelcer, N., Mann, K., Lamb, B., Willson, T. M., Collins, J. L., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.010 · Cited by 876
Self-citationCD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591 · cited 10×
“Neonatal primary microglia from C57BL/6J or IRAK4KI/KI neonatal mice were cultured from P0 –P3 mouse pups as previously described (Reed-Geaghan et al., 2009).”
BackgroundMethodResultInfluentialSelf-citationEdison, P., Archer, H. A., Gerhard, A., Hinz, R., Pavese, N., Turkheimer, F. E., Hammers, A., Tai, Y. F., Fox, N., Kennedy, A., et al. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.001 · Cited by 513
A Cell Surface Receptor Complex for Fibrillar β-Amyloid Mediates Microglial Activation
Bamberger, M. E., Harris, M. E., McDonald, D. R., Husemann, J., & Landreth, G. E. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02665.2003 · Cited by 501
Self-citationRole of toll-like receptor signalling in A uptake and clearance
Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., & Fukuchi, K.-I. (2006) · Brain · doi:10.1093/brain/awl249 · Cited by 493 · cited 4×
“Another study using a mouse model with defective TLR4 signaling demonstrated increased amyloid burden at advanced ages (Tahara et al., 2006; Song et al., 2011).”
BackgroundMethodInfluentialCD36 Mediates the Innate Host Response to β-Amyloid
El Khoury, J. B., Moore, K. J., Means, T. K., Leung, J., Terada, K., Toft, M., Freeman, M. W., & Luster, A. D. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021546 · Cited by 483
Koenigsknecht-Talboo, J., & Landreth, G. E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1808-05.2005 · Cited by 477 · cited 1×
“Moreover, our data demonstrate that activation of IRAK4 in microglia polarizes microglia toward a more inflammatory M1 state, one that is less favorable for clearance of amyloid (Koenigsknecht-Talboo and Landreth, 2005).”
BackgroundSelf-citationYang, D.-S., Stavrides, P., Mohan, P. S., Kaushik, S., Kumar, A., Ohno, M., Schmidt, S. D., Wesson, D., Bandyopadhyay, U., Jiang, Y., et al. (2011) · Brain · doi:10.1093/brain/awq341 · Cited by 429
Microglia Mediate the Clearance of Soluble Aβ through Fluid Phase Macropinocytosis
Mandrekar, S., Jiang, Q., Lee, C. Y. D., Koenigsknecht-Talboo, J., Holtzman, D. M., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5572-08.2009 · Cited by 415 · cited 1×
“In vitro studies demonstrated that there was no difference between WT and IRAK4 KI/KI microglia in their capacity for fluid phase uptake of soluble A (data not shown) (Burdick et al., 1992; Lorenzo and Yankner, 1994; Mandrekar et al., 2009), or for A stimulated phagocytic uptake of beads (data not shown) (Reed-Geaghan…”
ResultSelf-citationExpression profiles for macrophage alternative activation genes in AD and in mouse models of AD.
(2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-27 · Cited by 393 · cited 1×
“We also assessed activation of ERK kinases, which have been shown to be downstream of fA -induced inflammatory signaling (McDonald et al., 1998; Combs et al., 1999; Kim et al., 2004; Tahara et al., 2006; Giovannini et al., 2008; Song et al., 2011).”
MethodSheng, J. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(03)00069-x · Cited by 388 · cited 1×
“Acute TLR4 activation by LPS suppressed amyloid pathology (DiCarlo et al., 2001); however, sustained TLR4 activation resulted in increased amyloid deposition (Qiao et al., 2001; Sheng et al., 2003).”
BackgroundJimenez, S., Baglietto-Vargas, D., Caballero, C., Moreno-Gonzalez, I., Torres, M., Sanchez-Varo, R., Ruano, D., Vizuete, M., Gutierrez, A., & Vitorica, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3024-08.2008 · Cited by 383 · cited 1×
“Controversial findings from Jimenez et al. (2008) argue that as AD pathology progresses there is a switch from M2 toward an M1 state.”
BackgroundZhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378 · cited 2×
“Increases in activated forms of the p38 MAP kinase have been found in the brains of both mouse models of AD and AD patients (Hensley et al., 1999; Zhu et al., 2000; Savage et al., 2002; Jin et al., 2005; Giovannini et al., 2008; Meyer-Luehmann et al., 2008) and it is activated following microglia exposure to fA (McDon…”
Backgroundp38 Kinase Is Activated in the Alzheimer's Disease Brain
Hensley, K., Floyd, R. A., Zheng, N., Nael, R., Robinson, K. A., Nguyen, X., Pye, Q. N., Stewart, C. A., Geddes, J., Markesbery, W. R., et al. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722053.x · Cited by 373 · cited 2×
“Increases in activated forms of the p38 MAP kinase have been found in the brains of both mouse models of AD and AD patients (Hensley et al., 1999; Zhu et al., 2000; Savage et al., 2002; Jin et al., 2005; Giovannini et al., 2008; Meyer-Luehmann et al., 2008) and it is activated following microglia exposure to fA (McDon…”
BackgroundYamamoto, M., Kiyota, T., Horiba, M., Buescher, J. L., Walsh, S. M., Gendelman, H. E., & Ikezu, T. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.060378 · Cited by 367
Alternative activation of macrophages: immune function and cellular biology
Varin, A., & Gordon, S. (2009) · Immunobiology · doi:10.1016/j.imbio.2008.11.009 · Cited by 361 · cited 1×
“M1 and M2 macrophages, or microglia, are functionally distinct yet are plastic and transition between the various states (Gordon and Taylor, 2005; Varin and Gordon, 2009; Gordon and Martinez, 2010).”
Backgroundβ-Amyloid Activates the O⨪2 Forming NADPH Oxidase in Microglia, Monocytes, and Neutrophils
Della Bianca, V., Dusi, S., Bianchini, E., Dal Prà, I., & Rossi, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15493 · Cited by 324 · cited 1×
“…were purchased from Abcam. fA 1– 42 was generated by dissolving lyophilized A 1– 42 (American Peptide) in double-distilled, endotoxin-free water at a concentration of 1 mM and incubated at 37°C for 5 d and then stored at 4°C as previously described (Burdick et al., 1992; Lorenzo and Yankner, 1994).”
MethodRichard, K. L., Filali, M., Préfontaine, P., & Rivest, S. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.1146-08.2008 · Cited by 298 · cited 3×
“However, knock-out of TLR2 resulted in decreased amyloid burden at younger ages but no difference at older ages (Richard et al., 2008).”
BackgroundSavage, M. J., Lin, Y.-G., Ciallella, J. R., Flood, D. G., & Scott, R. W. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03376.2002 · Cited by 291 · cited 2×
“Increases in activated forms of the p38 MAP kinase have been found in the brains of both mouse models of AD and AD patients (Hensley et al., 1999; Zhu et al., 2000; Savage et al., 2002; Jin et al., 2005; Giovannini et al., 2008; Meyer-Luehmann et al., 2008) and it is activated following microglia exposure to fA (McDon…”
BackgroundOlfactory Dysfunction Correlates with Amyloid-β Burden in an Alzheimer's Disease Mouse Model
Wesson, D. W., Levy, E., Nixon, R. A., & Wilson, D. A. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4622-09.2010 · Cited by 290 · cited 4×
“…reactive gliosis Phenotypic activation of microglia and astrocytes in AD is associated with increases in inflammatory mediators and is correlated with the deposition of amyloid (Akiyama et al., 2000; Cameron and Landreth, 2010) and with cognitive decline (Edison et al., 2008; Wesson et al., 2010).”
BackgroundMethodResultInfluentialSong, M., Jin, J., Lim, J.-E., Kou, J., Pattanayak, A., Rehman, J. A., Kim, H.-D., Tahara, K., Lalonde, R., & Fukuchi, K.-I. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-92 · Cited by 273 · cited 4×
“Another study using a mouse model with defective TLR4 signaling demonstrated increased amyloid burden at advanced ages (Tahara et al., 2006; Song et al., 2011).”
BackgroundMethodInfluentialMorphologic association between microglia and senile plaque amyloid in Alzheimer's disease
Perlmutter, L. S., Barron, E., & Chui, H. C. (1990) · Neuroscience Letters · doi:10.1016/0304-3940(90)90748-x · Cited by 240
Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice
DiCarlo, G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00292-5 · Cited by 223
Chakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T. E., & Das, P. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903382 · Cited by 206 · cited 2×
“5C), we also investigated the complement pathway based on evidence that IFN can in- duce complement and drive clearance of amyloid (Negishi et al., 2005; Chakrabarty et al., 2010).”
BackgroundMethodScholtzova, H., Kascsak, R. J., Bates, K. A., Boutajangout, A., Kerr, D. J., Meeker, H. C., Mehta, P. D., Spinner, D. S., & Wisniewski, T. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5715-08.2009 · Cited by 166 · cited 2×
“These studies are congruent with those of Scholtzova et al. (2009) who reported that TLR9 activation was associated with reduced amyloid deposition, a treatment that is known to drive a strong interferon response (Kawai and Akira, 2011).”
ResultIFN Regulatory Factor 4 Regulates the Expression of a Subset of Th2 Cytokines
Ahyi, A.-N. N., Chang, H.-C., Dent, A. L., Nutt, S. L., & Kaplan, M. H. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803302 · Cited by 137 · cited 1×
“IRF4 is associated with an M2 state (Ahyi et al., 2009) whereas IRF5 is associated with activation of an M1 state and suppression of an M2 state (Takaoka et al., 2005; Krausgruber et al., 2011).”
BackgroundNeuroinflammation‐induced acceleration of amyloid deposition in the APPV717F transgenic mouse
Qiao, X., Cummins, D. J., & Paul, S. M. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01666.x · Cited by 119 · cited 2×
“, 2001); however, sustained TLR4 activation resulted in increased amyloid deposition (Qiao et al., 2001; Sheng et al., 2003).”
BackgroundMyD88 Deficiency Ameliorates β-Amyloidosis in an Animal Model of Alzheimer's Disease
Lim, J.-E., Kou, J., Song, M., Pattanayak, A., Jin, J., Lalonde, R., & Fukuchi, K.-I. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.05.045 · Cited by 63 · cited 1×
“Knock-out of MyD88 resulted in decreased in soluble, oligomeric, and fA levels and decreased macrophage activation but without any changes in behavior (Hao et al., 2011; Lim et al., 2011, 2012).”
BackgroundMichaud, J.-P., Richard, K. L., & Rivest, S. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-5 · Cited by 48 · cited 1×
“In contrast, MyD88 haploinsufficiency delayed amyloid deposition, but impaired spatial memory and was associated with increased oligomeric A species (Michaud et al., 2011).”
Background
Cited by
Innate immune activation in neurodegenerative disease
Heneka, M. T., Kummer, M. P., & Latz, E. (2014) · Nature Reviews Immunology · doi:10.1038/nri3705 · Cited by 1,437
Compromised MAPK signaling in human diseases: an update
Kim, E. K., & Choi, E.-J. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1472-2 · Cited by 1,020
Innate immunity in Alzheimer's disease
Heneka, M. T., Golenbock, D. T., & Latz, E. (2015) · Nature Immunology · doi:10.1038/ni.3102 · Cited by 902
Norden, D. M., Trojanowski, P. J., Villanueva, E., Navarro, E., & Godbout, J. P. (2016) · Glia · doi:10.1002/glia.22930 · Cited by 590
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Metadata
- Authors
- Cameron, B., Tse, W., Lamb, R., Li, X., Lamb, B. T., & Landreth, G. E.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2012-10-24
- Volume
- 32
- Issue
- 43
- Pages
- 15112-15123
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W1983430176
- Cited by
- 73
- References
- 43
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.